Strikingly, it was orchestrated by fused in sarcoma (FUS) protein, and not by directly altering PTPIP51- VAPB expression, but by activating glycogen synthase kinase 3-beta (GSK-3b), evidencing a correlation between this molecule and ALS. The gene discussed is GSK3B; the disease is amyotrophic lateral sclerosis.